IE38220L - 4(1h)-pyrimidine compounds - Google Patents
4(1h)-pyrimidine compoundsInfo
- Publication number
- IE38220L IE38220L IE158573A IE158573A IE38220L IE 38220 L IE38220 L IE 38220L IE 158573 A IE158573 A IE 158573A IE 158573 A IE158573 A IE 158573A IE 38220 L IE38220 L IE 38220L
- Authority
- IE
- Ireland
- Prior art keywords
- alkyl
- hydrogen
- group
- replaced
- acid
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 11
- 229910052739 hydrogen Inorganic materials 0.000 abstract 9
- 239000001257 hydrogen Substances 0.000 abstract 9
- 229910052760 oxygen Inorganic materials 0.000 abstract 8
- 150000002431 hydrogen Chemical class 0.000 abstract 6
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 6
- 150000001875 compounds Chemical class 0.000 abstract 5
- 229910052717 sulfur Inorganic materials 0.000 abstract 5
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 3
- 125000002947 alkylene group Chemical group 0.000 abstract 3
- 125000000304 alkynyl group Chemical group 0.000 abstract 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 3
- 238000010438 heat treatment Methods 0.000 abstract 3
- 239000001301 oxygen Substances 0.000 abstract 3
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 abstract 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- -1 alkoxycarbonyl halogen Chemical class 0.000 abstract 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 abstract 1
- LLKCXVWITGBXLG-UHFFFAOYSA-N 2-cyano-3-morpholin-4-ylprop-2-enamide Chemical compound NC(=O)C(C#N)=CN1CCOCC1 LLKCXVWITGBXLG-UHFFFAOYSA-N 0.000 abstract 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 abstract 1
- SVOQOFSQLVVHKQ-UHFFFAOYSA-N 6-oxo-1h-pyrimidine-5-carbonitrile Chemical class O=C1NC=NC=C1C#N SVOQOFSQLVVHKQ-UHFFFAOYSA-N 0.000 abstract 1
- CFEYBLWMNFZOPB-UHFFFAOYSA-N Allylacetonitrile Natural products C=CCCC#N CFEYBLWMNFZOPB-UHFFFAOYSA-N 0.000 abstract 1
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 abstract 1
- 206010052895 Coronary artery insufficiency Diseases 0.000 abstract 1
- 201000005569 Gout Diseases 0.000 abstract 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- 150000008065 acid anhydrides Chemical class 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 206010003119 arrhythmia Diseases 0.000 abstract 1
- 230000006793 arrhythmia Effects 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- DGJMPUGMZIKDRO-UHFFFAOYSA-N cyanoacetamide Chemical compound NC(=O)CC#N DGJMPUGMZIKDRO-UHFFFAOYSA-N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 abstract 1
- 235000019253 formic acid Nutrition 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/52—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing groups, e.g. carboxylic acid amidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/72—Hydrazones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Zoology (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
1427190 5-Cyano-4-pyrimidinone derivatives BYK GULDEN LOMBERG CHEMISCHE FABRIK GmbH 5 Sept 1973 [8 Sept 1972 (4)] 41668/73 Heading C2C Novel compounds I in which R<SP>3</SP> is in which R<SP>4</SP> is hydrogen, a C 1-14 alkyl C 2-7 alkenyl or C 2-7 alkynyl group in which a methylene group may be replaced by oxygen and the alkyl group may be substituted by an NR<SP>5</SP>R<SP>6</SP> group C 3-6 cycloalkyl optionally substituted by an NR<SP>5</SP>R<SP>6</SP> group, a phenyl or phenyl-C 1-6 alkyl group (optionally substituted in the ring by C 1-7 alkyl, C 1-7 alkoxy, C 1-7 alkylthio, C 2-5 alkoxycarbonyl halogen, trifluoromethyl, nitro and/or cyano) R<SP>5</SP> and R<SP>6</SP> are hydrogen, a C 1-7 alkyl, C 2-7 alkenyl or C 2-7 alkynyl group in which a methylene group may be replaced by oxygen, or C 3-6 cycloalkyl or R 5 and R 6 together represent C 2-5 alkylene (in which one or more methylene groups may be replaced by O, S or NR<SP>7</SP>), X is O, S or NR<SP>7</SP>, Y is O, S or NH and R<SP>7</SP> is hydrogen, C 1-7 alkyl, C 2-7 alkenyl or C 2-7 alkynyl and their salts are prepared by (1) treating a compound II in which R<SP>1</SP> and R<SP>2</SP> are C 1-7 alkyl or R<SP>1</SP> and R<SP>2</SP> together represent C 2-5 alkylene in which one or more methylene groups may be replaced by O, S or NR<SP>7</SP> (in which R<SP>7</SP> is hydrogen or C 1-7 alkyl) with an acid (2) heating or reacting with an acid or compound III in which A and B are hydrogen, hydroxy, C 1-7 alkoxy NR<SP>8</SP>R<SP>9</SP> or NR<SP>8</SP>-COR<SP>9</SP> (in which R<SP>8</SP> and R<SP>9</SP> are hydrogen, C 1-7 alkyl in which a methylene group may be replaced by oxygen, C 3-6 cycloalkyl or R<SP>8</SP> and R<SP>9</SP> together represent C 2-5 alkylene in which one or more methylene groups may be replaced by O, S or NR<SP>7</SP> and R<SP>7</SP> is hydrogen or C 1-7 alkyl) (3) heating or treating with an acid a compound IV in which R<SP>1</SP> and R<SP>2</SP> is addition to the above definitions, may be a phenyl group or one of R<SP>1</SP> and R<SP>2</SP> may additionally be hydrogen or (4) cyanacetamide is reacted with a trialkyl orthoformate HC(OR) 3 or a dialkoxymethyl ester of an organic carboxylic acid R*COOCH(OR) 2 (in which R is C 1-7 alkyl, and R* is hydrogen, C 1-7 alkyl, aryl, aralkyl or cycloalkyl) in the presence of an acid anhydride and the resulting product reacted with a hydrazine R 3 -NHNH 2 . In the compounds prepared R<SP>3</SP> is C 1-12 alkoxycarbonyl, benzyloxycarbonyl, phenoxycarbonyl cyclohexyloxycarbonyl, #-methoxyethoxycarbonyl, benzamido, #-iso-propoxyethoxycarbonyl, allyloxycarbonyl, acetyl or pmethoxybenzoyl. 2 - Morpholinomethylidene - 3 - oxo - 4 - aza- 5 - (N<SP>1</SP> - acetylhydrazino) - 4 - pentenenitrile is prepared by heating together 3-morpholino-2- cyano-acrylamide, triethylorthoformate, acetic anhydride and formic acid. Compounds I are used to prepare compounds IV or its tautomers by reaction with an amine R 1 R 2 NH; compound IV (R 1 R 2 N=N-methylpiperazine, R<SP>3</SP>=COOMe) is prepared. Compounds I may be used to treat gout, coronary insufficiency and arrhythmia. They form with a suitable vehicle a pharmaceutical composition which may be administered orally or parenterally.
[GB1427190A]
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU66036 | 1972-09-08 | ||
| LU66038 | 1972-09-08 | ||
| LU66039 | 1972-09-08 | ||
| LU66037 | 1972-09-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE38220L true IE38220L (en) | 1974-03-08 |
| IE38220B1 IE38220B1 (en) | 1978-01-18 |
Family
ID=27483584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE158573A IE38220B1 (en) | 1972-09-08 | 1973-09-06 | 4(1h)-pyrimidinone compounds,a method for producing them andmedicamentes containing them |
Country Status (8)
| Country | Link |
|---|---|
| JP (1) | JPS4962488A (en) |
| CA (1) | CA1008073A (en) |
| CH (1) | CH593265A5 (en) |
| DE (1) | DE2344757C3 (en) |
| FR (1) | FR2198747B1 (en) |
| GB (1) | GB1427190A (en) |
| IE (1) | IE38220B1 (en) |
| NL (1) | NL7312336A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999024038A1 (en) | 1997-11-07 | 1999-05-20 | Johns Hopkins University | Methods for treatment of disorders of cardiac contractility |
-
1973
- 1973-09-05 DE DE19732344757 patent/DE2344757C3/en not_active Expired
- 1973-09-05 GB GB4166873A patent/GB1427190A/en not_active Expired
- 1973-09-05 CH CH1271973A patent/CH593265A5/xx not_active IP Right Cessation
- 1973-09-06 IE IE158573A patent/IE38220B1/en unknown
- 1973-09-06 CA CA180,398A patent/CA1008073A/en not_active Expired
- 1973-09-07 FR FR7332263A patent/FR2198747B1/fr not_active Expired
- 1973-09-07 JP JP48101039A patent/JPS4962488A/ja active Pending
- 1973-09-07 NL NL7312336A patent/NL7312336A/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NL7312336A (en) | 1974-03-12 |
| CA1008073A (en) | 1977-04-05 |
| FR2198747B1 (en) | 1977-01-28 |
| IE38220B1 (en) | 1978-01-18 |
| DE2344757A1 (en) | 1974-04-11 |
| GB1427190A (en) | 1976-03-10 |
| FR2198747A1 (en) | 1974-04-05 |
| CH593265A5 (en) | 1977-11-30 |
| DE2344757B2 (en) | 1978-01-05 |
| DE2344757C3 (en) | 1978-09-14 |
| JPS4962488A (en) | 1974-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1327308A (en) | Process for preparing aroyl-substituted pyrroles and product prepared thereby | |
| DE69712745T2 (en) | PYRROLOPYRIMIDINES AND METHOD FOR THE PRODUCTION THEREOF | |
| NZ337724A (en) | 1,5-dihydro-pyrazolo[3,4-d]-pyrimidinone derivatives in particular for the treatment of cardiovascular and cerebrovascular diseases, diseases of the peripheral vessels and diseases of the urogenital system | |
| IE36797B1 (en) | Derivatives of benzodiazepines | |
| US3487087A (en) | Nitration of imidazoles | |
| GB1478364A (en) | 3-5-nitro-2-imidazolyl-pyrazoles | |
| GB1506914A (en) | 2-dihalophenylamino-2-imidazoline derivatives | |
| DD242045A5 (en) | NEW PYROLO-BENZIMIDAZOLE, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE COMPOUNDS | |
| GB1196229A (en) | Improvements in or relating to a New Glyoxylic Acid Salt, process for its preparation and Therapeutical Composition containing same | |
| IE37795L (en) | Quinaldamide derivatives | |
| IE38220L (en) | 4(1h)-pyrimidine compounds | |
| GB1291417A (en) | Nitrofuryl-triazole-pyrimidines | |
| GB1331015A (en) | 1-substituted-6-phenyl-4h-s-triazolo-4,3-a-1,4-benzodiazepines | |
| ES358796A1 (en) | 2-halomethyl-3-carboxylic acid amido-quinoxaline-1,4-di-n-oxides and their production | |
| GB1070243A (en) | S-triazolopyrimidones, their preparation and compositions containing them | |
| GB1409871A (en) | Imidazo 4,5-f quinolin-9-ols | |
| US3196165A (en) | N-alkanoylamido-5-nitro-2-furamidines | |
| GB1444690A (en) | N6-2-bicyclo-2,2,2-octyl-adenine derivatives and preparation thereof | |
| GB1201977A (en) | Penicilloic acid derivatives and a process for the manufacture thereof | |
| DE2150516C3 (en) | 7- [α-Amino-1'-cyclohexenyl-acetamido] -cephalosporanic acids and process for their preparation | |
| GB1325280A (en) | 3-substituted-as-triazino-5,6-c-quinolines | |
| GB1476860A (en) | Substituted quinoxaline-2-carboxamide-1,4-dioxides | |
| GB1333510A (en) | Malonyl urea derivatives process for their preparation and compositions incorporating them | |
| GB1129358A (en) | 5,8-dihydro-5-oxopyrido[2,3-d]pyrimidine derivatives, and processes for the preparation thereof | |
| DE2261693A1 (en) | Anti-microbial nitroimidazolyl-triazolo-pyridazines - used in pharma-ceuticals, prepd via amination or cyclisation reactions |